cached image

Gjumrakch Aliev, MD - Publications

Affiliations: 
University of Atlanta 
Area:
Alzheimer's disease, atherosclerosis, cancer, antioxidant treatment

169 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Herrera AS, Arias Esparza MDC, Arias PES, Ashraf GM, Mosa OF, Sokolov AV, Bovina EV, Chubarev VN, Tarasov VV, Aliev G. The Role of Melanin as Magic Bullets in the Water Dissociating Reaction in the Retinopathy of Prematurity. Central Nervous System Agents in Medicinal Chemistry. PMID 31267880 DOI: 10.2174/1871524919666190702164206  0.6
2019 Makara-Studzińska M, Somasundaram S, Ashraf GM, Gogacz M, Madej A, Izydorczyk B, Leszek J, Lebedeva SA, Chubarev VN, Tarasov VV, Kirkland E, Aliev G. Assessment of Psychosocial Functioning of Mothers of Children with Diabetes Mellitus Compared to Mothers of Healthy Children. Biomed Research International. 2019: 6821575. PMID 31093501 DOI: 10.1155/2019/6821575  0.68
2019 Aliev G, Li Y, Chubarev VN, Lebedeva SA, Parshina LN, Trofimov BA, Sologova SS, Makhmutova A, Avila-Rodriguez MF, Klochkov SG, Galenko-Yaroshevsky PA, Tarasov VV. Application of Acyzol in the Context of Zinc Deficiency and Perspectives. International Journal of Molecular Sciences. 20. PMID 31035445 DOI: 10.3390/ijms20092104  0.68
2018 Aliev G, Ashraf GM, Tarasov VV, Chubarev VN, Leszek J, Gasiorowski K, Makhmutovа A, Baeesa SS, Avila-Rodriguez M, Ustyugov AA, Bachurin SO. Alzheimer Disease - Future Therapy Based on Dendrimers. Current Neuropharmacology. PMID 30227819 DOI: 10.2174/1570159X16666180918164623  0.68
2018 Herrera AS, Ashraf GM, Del Carmen Arias Esparza M, Tarasov VV, Chubarev VN, Avila-Rodriguez MF, Makhmutovа A, Ganash M, Hafeez A, Bachurin SO, Aliev G. Cerebrospinal Fluid, Brain Electrolytes Balance, and the Unsuspected Intrinsic Property of Melanin to Dissociate the Water Molecule Cns & Neurological Disorders Drug Targets. PMID 30179148 DOI: 10.2174/1871527317666180904093430  0.6
2018 Brzecka A, Leszek J, Ashraf GM, Ejma M, Ávila-Rodriguez MF, Yarla NS, Tarasov VV, Chubarev VN, Samsonova AN, Barreto GE, Aliev G. Sleep Disorders Associated With Alzheimer's Disease: A Perspective. Frontiers in Neuroscience. 12: 330. PMID 29904334 DOI: 10.3389/fnins.2018.00330  0.68
2018 Carrera I, Fernandez-Novoa L, Sampedro C, Cacabelos R, Aliev G. Dopaminergic neuroprotection with Atremorine in Parkinson´s disease. Current Medicinal Chemistry. PMID 29637853 DOI: 10.2174/0929867325666180410100559  0.56
2017 Putta S, Yarla NS, Kumar EK, Lakkappa DB, Kamal MA, Scotti L, Scotti MT, Ashraf GM, Barreto GE, Rao BSB, Kumari DS, Reddy GV, Tarasov VV, Imandi SB, Aliev G. Preventive and Therapeutic potentials of Anthocyanins in diabetes and associated complications. Current Medicinal Chemistry. PMID 29210634 DOI: 10.2174/0929867325666171206101945  0.56
2017 Nemtsova MV, Strelnikov VV, Tanas AS, Bykov II, Zaletaev DV, Rudenko VV, Glukhov AI, Kchorobrich TV, Li Y, Tarasov VV, Barreto GE, Aliev G. Implication of Gastric Cancer Molecular Genetic Markers in Surgical Practice. Current Genomics. 18: 408-415. PMID 29081696 DOI: 10.2174/1389202918666170329110021  0.68
2017 Aliev G, Barreto GE, Cacabelos R. Editorial: Genomics and Epigenomics of Tumor and Aging Cells. Current Genomics. 18: 375-377. PMID 29081693 DOI: 10.2174/138920291805170817124855  0.56
2017 Putta S, Peluso I, Yarla NS, Kilari EK, Bishayee A, Lu DY, Barreto GE, Ashraf GM, Scotti L, Scotti MT, Singla RK, Alexiou T, Atanasov AG, Tarasov VV, Bramhachari PV, ... ... Aliev G, et al. Diabetes mellitus and male aging: Pharmacotherapeutics and clinical implications. Current Pharmaceutical Design. PMID 28831925 DOI: 10.2174/1381612823666170823103830  0.56
2017 Rayavarapu S, Yarla NS, Kadiri SK, Bishayee A, Vidavalur S, Tadikonda R, Basha M, Pidugu VR, Dowluru KSVGK, Lakappa DB, Kamal MA, Md Ashraf G, Tarasov VV, Chubarev VN, Klochkov SG, ... ... Aliev G, et al. Synthesis of Saccharumoside-B analogue with potential of antiproliferative and pro-apoptotic activities. Scientific Reports. 7: 8309. PMID 28814788 DOI: 10.1038/s41598-017-05832-w  0.56
2017 Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Chari VB, Reddy D RS, Bade R, Mannarapu M, Barretto G, Lu DY, Tarasov VV, ... ... Aliev G, et al. Anthocyanins: Possible role as Multitarget therapeutic agents for prevention and therapy of chronic diseases. Current Pharmaceutical Design. PMID 28741457 DOI: 10.2174/1381612823666170519151801  1
2017 Sawikr Y, Yarla NS, Peluso I, Kamal MA, Aliev G, Bishayee A. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals. Advances in Protein Chemistry and Structural Biology. 108: 33-57. PMID 28427563 DOI: 10.1016/bs.apcsb.2017.02.001  0.56
2017 Leszek J, Tse WH, Zhang J, Ávila-Rodriguez MF, Tarasov VV, Barreto GE, Bachurin SO, Aliev G. Nanotechnology for Alzheimer Disease. Current Alzheimer Research. PMID 28164767 DOI: 10.2174/1567205014666170203125008  0.68
2017 Ghotme KA, Barreto GE, Echeverria V, Gonzalez J, Bustos RH, Sanchez M, Leszek J, Yarla NS, Gomez RM, Tarasov VV, Ashraf GM, Aliev G. Gliomas: New Perspectives in Diagnosis, Treatment and Prognosis. Current Topics in Medicinal Chemistry. 17: 1438-1447. PMID 28049399 DOI: 10.2174/1568026617666170103162639  0.68
2017 Gąsiorowski K, Brokos B, Leszek J, Ashraf GM, Aliev G. Insulin Resistance in Alzheimer Disease: p53 and MicroRNAs as Important Players. Current Topics in Medicinal Chemistry. PMID 28049397  0.68
2017 Leszek J, Trypka E, Tarasov VV, Md Ashraf G, Aliev G. Type 3 Diabetes Mellitus: A Novel Implication of Alzheimer Disease. Current Topics in Medicinal Chemistry. PMID 28049395  0.68
2016 Corzo L, Rodríguez S, Alejo R, Fernández-Novoa L, Aliev G, Cacabelos R. E-MHK-0103 (Mineraxin™): A Novel Nutraceutical with Biological Properties in Menopausal Conditions. Current Drug Metabolism. PMID 27756198  0.56
2016 Leszek J, Trypka E, Koutsourak E, Michmizos D, Ashraf GM, Aliev G. Late-life depression and Alzheimer disease: a potential synergy of the underlying mechanisms. Current Medicinal Chemistry. PMID 27593962  0.68
2016 Khan MF, Ansari AH, Hameedullah M, Ahmad E, Husain FM, Zia Q, Baig U, Zaheer MR, Alam MM, Khan AM, AlOthman ZA, Ahmad I, Ashraf GM, Aliev G. Sol-gel synthesis of thorn-like ZnO nanoparticles endorsing mechanical stirring effect and their antimicrobial activities: Potential role as nano-antibiotics. Scientific Reports. 6: 27689. PMID 27349836 DOI: 10.1038/srep27689  1
2016 Cacabelos R, Reddy VP, Aliev G. Editorial: Neurodegeneration, Oxidative Stress, Metabolic Syndrome, Drug Design and Development: Clinical Implications. Cns & Neurological Disorders Drug Targets. 15: 126. PMID 26907796  0.72
2016 Cacabelos R, Torrellas C, Carrera I, Cacabelos P, Corzo L, Fernández-Novoa L, Tellado I, Carril JC, Aliev G. Novel Therapeutic Strategies for Dementia. Cns & Neurological Disorders Drug Targets. PMID 26831267  0.56
2016 Herrera AS, Del Carmen Arias Esparza M, Solís Arias PE, Barreto GE, Li Y, Bachurin SO, Aliev G. Unsuspected Intrinsic Property of Melanin to Dissociate Water Can Be Used for the Treatment of CNS Diseases. Cns & Neurological Disorders Drug Targets. PMID 26831264  0.68
2016 Ashraf GM, Ali A, Tabrez S, Zaidi SK, Shakil S, Alam MZ, Rehan M, Aliev G. Linkage of Stress with Neuromuscular Disorders. Cns & Neurological Disorders Drug Targets. PMID 26831261  0.56
2016 Leszek J, Barreto GE, Gąsiorowski K, Koutsouraki E, Ávila-Rodrigues M, Aliev G. Inflammatory Mechanisms and Oxidative Stress as Key Factors Responsible for Progression of Neurodegeneration: Role of Brain Innate Immune System. Cns & Neurological Disorders Drug Targets. PMID 26831258  0.68
2015 Aliev G, Cacabelos R, Prakash Reddy V. Editorial: Metabolic Disorders, Drug Development, Drug Design and Biomarkers. Current Pharmaceutical Design. PMID 26708826  0.56
2015 Cacabelos R, Torrellas C, Fernández-Novoa L, Aliev G. Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection. Current Pharmaceutical Design. PMID 26648474  0.56
2015 Zia Q, Azhar A, Kamal MA, Aliev G, Owais M, Ashraf GM. Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index. Current Pharmaceutical Design. PMID 26648472  1
2015 Carrera I, Fernandez-Novoa L, Aliev G, Vigo C, Cacabelos R. Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine. Current Pharmaceutical Design. PMID 26648469  0.56
2015 Korada SK, Yarla NS, Bishayee A, Aliev G, Aruna Lakshmi K, Arunasree MK, Dananajaya BL, Mishra V. Can probiotics cure inflammatory bowel diseases? Current Pharmaceutical Design. PMID 26648465  1
2015 Aliev G, Daza J, Herrera AS, del Carmen Arias Esparza M, Morales L, Echeverria V, Bachurin SO, Barreto GE. Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis. Cns & Neurological Disorders Drug Targets. 14: 1235-42. PMID 26295828  0.72
2015 Neganova ME, Klochkov SG, Afanasieva SV, Serkova TP, Chudinova ES, Bachurin SO, Reddy VP, Aliev G, Shevtsova EF. Neuroprotective effects of the securinine-analogues: identification of Allomargaritarine as a lead compound. Cns & Neurological Disorders Drug Targets. PMID 26295814  0.72
2015 Makhaeva GF, Lushchekina SV, Boltneva NP, Sokolov VB, Grigoriev VV, Serebryakova OG, Vikhareva EA, Aksinenko AY, Barreto GE, Aliev G, Bachurin SO. Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer Disease. Scientific Reports. 5: 13164. PMID 26281952 DOI: 10.1038/srep13164  1
2015 Barragan-Osorio L, Giraldo G, Almeciga-Diaz CJ, Aliev G, Barreto GE, Gonzalez J. Computational Analysis And Functional Prediction Of Ubiquitin Hypothetical Protein: A Possible Target In Parkinson Disease. Central Nervous System Agents in Medicinal Chemistry. PMID 26201532  1
2015 Blach-Olszewska Z, Zaczynska E, Gustaw-Rothenberg K, Avila-Rodrigues M, Barreto GE, Leszek J, Aliev G. The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy. Current Pharmaceutical Design. 21: 3582-8. PMID 26166611  0.68
2015 Savvateeva LV, Schwartz AM, Gorshkova LB, Gorokhovets NV, Makarov VA, Reddy VP, Aliev G, Jr Zamyatnin AA. Prophylactic Admission of an In Vitro Reconstructed Complexes of Human Recombinant Heat Shock Proteins and Melanoma Antigenic Peptides Activates Anti-Melanoma Responses in Mice. Current Molecular Medicine. PMID 26122656  0.72
2015 Torrente D, Cabezas R, Avila M, Sanchez Y, Morales L, Ashraf GM, Barreto GE, Gonzalez J, Aliev G. Mechanisms of PDGFRalpha promiscuity and PDGFRbeta specificity in association with PDGFB. Frontiers in Bioscience (Elite Edition). 7: 434-46. PMID 25961423  1
2015 Solis-Herrera A, Ashraf GM, Del C A Esparza M, Arias RI, Bachurin SO, Barreto GE, Aliev G. Biological Activities of QIAPI 1 as a Melanin Precursor and Its Therapeutic Effects in Wistar Rats Exposed to Arsenic Poisoning. Central Nervous System Agents in Medicinal Chemistry. 15: 99-108. PMID 25909193  1
2015 Siew Hua G, Kamal MA, Lima MM, Khalil MI, Pasupuleti VR, Aliev G. Medicinal plants in management of type 2 diabetes and neurodegenerative disorders. Evidence-Based Complementary and Alternative Medicine : Ecam. 2015: 686872. PMID 25873981 DOI: 10.1155/2015/686872  1
2015 Savvateeva LV, Gorokhovets NV, Makarov VA, Serebryakova MV, Solovyev AG, Morozov SY, Reddy VP, Zernii EY, Zamyatnin AA, Aliev G. Glutenase and collagenase activities of wheat cysteine protease Triticain-α: feasibility for enzymatic therapy assays. The International Journal of Biochemistry & Cell Biology. 62: 115-24. PMID 25765959 DOI: 10.1016/j.biocel.2015.03.001  1
2015 Aliev G. Preface. Central Nervous System Agents in Medicinal Chemistry. 15: 3. PMID 25756817  1
2015 Aliev G. Meet the editorial board. Central Nervous System Agents in Medicinal Chemistry. 15: 2. PMID 25756816  1
2015 Baksheeva VE, Nazipova AA, Zinchenko DV, Serebryakova MV, Senin II, Permyakov SE, Philippov PP, Li Y, Zamyatnin AA, Zernii EY, Aliev G. Ca2+ -myristoyl switch in neuronal calcium sensor-1: a role of C-terminal segment. Cns & Neurological Disorders Drug Targets. 14: 437-51. PMID 25714968  0.68
2015 Herrera AS, Del C A Esparza M, Md Ashraf G, Zamyatnin AA, Aliev G. Beyond mitochondria, what would be the energy source of the cell? Central Nervous System Agents in Medicinal Chemistry. 15: 32-41. PMID 25645910  1
2015 Iomdina EN, Khoroshilova-Maslova IP, Robustova OV, Averina OA, Kovaleva NA, Aliev G, Reddy VP, Zamyatnin AA, Skulachev MV, Senin II, Skulachev VP. Mitochondria-targeted antioxidant SkQ1 reverses glaucomatous lesions in rabbits. Frontiers in Bioscience (Landmark Edition). 20: 892-901. PMID 25553485  1
2015 Grieg NH, Kamal MA, Jabir NR, Tabrez S, Nasim FH, Abuzenadah AM, Aliev G. Specific cholinesterase inhibitors: A potential tool to assist in management of alzheimer disease Drug Design and Discovery in Alzheimer's Disease. 366-386. DOI: 10.1016/B978-0-12-803959-5.50006-4  1
2015 Aliev G. Meet Our editorial board member Cardiovascular and Hematological Agents in Medicinal Chemistry. 13: 71.  1
2015 Blach-Olszewska Z, Zaczynska E, Gustaw-Rothenberg K, Avila-Rodrigues M, Barreto GE, Leszek J, Aliev G. The innate immunity in alzheimer disease-relevance to pathogenesis and therapy Current Pharmaceutical Design. 21: 3582-3588.  1
2015 Savvateeva LV, Schwartz AM, Gorshkova LB, Gorokhovets NV, Makarov VA, Reddy VP, Aliev G, Zamyatnin AA. Prophylactic admission of an in vitro reconstructed complexes of human recombinant heat shock proteins and Melanom Antigenic peptides activates anti-melanoma responses in mice Current Molecular Medicine. 15: 462-468.  1
2015 Baksheeva VE, Nazipova AA, Zinchenko DV, Serebryakova MV, Senin II, Permyakov SE, Philippov PP, Li Y, Zamyatnin AA, Zernii EY, Aliev G. Ca2+-myristoyl switch in neuronal calcium sensor-1: A role of C-terminal segment Cns and Neurological Disorders - Drug Targets. 14: 437-451.  1
2015 Aliev G. Meet our editorial board members Current Genomics. 16.  1
2014 Kosenko EA, Tikhonova LA, Reddy VP, Aliev G, Kaminsky YG. Differential up-regulation of ammonia detoxifying enzymes in cerebral cortex, cerebellum, hippocampus, striatum and liver in hyperammonemia. Cns & Neurological Disorders Drug Targets. 13: 1089-95. PMID 25106624  1
2014 Tikhonova LA, Kaminsky YG, Reddy VP, Li Y, Solomadin IN, Kosenko EA, Aliev G. Impact of amyloid β25-35 on membrane stability, energy metabolism, and antioxidant enzymes in erythrocytes. American Journal of Alzheimer's Disease and Other Dementias. 29: 685-95. PMID 24838531 DOI: 10.1177/1533317514534757  1
2014 Shevtsova EF, Vinogradova DV, Kireeva EG, Reddy VP, Aliev G, Bachurin SO. Dimebon attenuates the Aβ-induced mitochondrial permeabilization. Current Alzheimer Research. 11: 422-9. PMID 24801220 DOI: 10.2174/1567205011666140505094808  0.68
2014 Aliev G, Priyadarshini M, Reddy VP, Grieg NH, Kaminsky Y, Cacabelos R, Ashraf GM, Jabir NR, Kamal MA, Nikolenko VN, Zamyatnin AA, Benberin VV, Bachurin SO. Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Current Medicinal Chemistry. 21: 2208-17. PMID 24372221 DOI: 10.2174/0929867321666131227161303  0.68
2014 Aliev G, Shahida K, Gan SH, Firoz C, Khan A, Abuzenadah AM, Kamal W, Kamal MA, Tan Y, Qu X, Reale M. Alzheimer disease and type 2 diabetes mellitus: the link to tyrosine hydroxylase and probable nutritional strategies. Cns & Neurological Disorders Drug Targets. 13: 467-77. PMID 24059309 DOI: 10.2174/18715273113126660153  0.68
2014 Kosenko EA, Solomadin IN, Tikhonova LA, Reddy VP, Aliev G, Kaminsky YG. Pathogenesis of Alzheimer disease: role of oxidative stress, amyloid-β peptides, systemic ammonia and erythrocyte energy metabolism. Cns & Neurological Disorders Drug Targets. 13: 112-9. PMID 24040810  0.68
2014 Prakash Reddy V, Mehta J, Aliev G. Role of α-Lipoid Acid and Acetyl-L-Carnitine in Dementia Diet and Nutrition in Dementia and Cognitive Decline. 955-962. DOI: 10.1016/B978-0-12-407824-6.00088-4  1
2014 Kotel'Nikova RA, Grigoriev VV, Smolina AV, Faingold II, Mishchenko DV, Van'Kin GI, Zamoiskii VL, Poletaeva DA, Markova NA, Romanova VS, Kotel'Nikov AI, Aliev G, Bachurin SO. Design of a hybrid nanostructure based on fullerene C60 and biologically active substance for modeling physiological properties of compounds Russian Chemical Bulletin. 63: 2375-2382. DOI: 10.1007/s11172-014-0750-0  1
2013 Carrera I, Etcheverria I, Li Y, Fernandez-Novoa L, Lombardi V, Vigo C, Palacios HH, Benberin VV, Cacabelos R, Aliev G. Immunocytochemical Characterization of Alzheimer's Disease Hallmarks in APP/PS1 Transgenic Mice Treated with a New Anti-Amyloid- Vaccine. Central Asian Journal of Global Health. 2: 119. PMID 29805876 DOI: 10.5195/cajgh.2013.119  0.72
2013 Kaminsky YG, Reddy VP, Ashraf GM, Ahmad A, Benberin VV, Kosenko EA, Aliev G. Age-related defects in erythrocyte 2,3-diphosphoglycerate metabolism in dementia. Aging and Disease. 4: 244-55. PMID 24124630 DOI: 10.14336/AD.2013.0400244  1
2013 Carrera I, Etcheverría I, Li Y, Fernández-Novoa L, Lombardi V, Vigo C, Palacios HH, Benberin VV, Cacabelos R, Aliev G. Immunocytochemical characterization of Alzheimer disease hallmarks in APP/PS1 transgenic mice treated with a new anti-amyloid-β vaccine. Biomed Research International. 2013: 709145. PMID 24089686 DOI: 10.1155/2013/709145  0.68
2013 Aliev G, Ashraf GM, Kaminsky YG, Sheikh IA, Sudakov SK, Yakhno NN, Benberin VV, Bachurin SO. Implication of the nutritional and nonnutritional factors in the context of preservation of cognitive performance in patients with dementia/depression and Alzheimer disease. American Journal of Alzheimer's Disease and Other Dementias. 28: 660-70. PMID 24085255 DOI: 10.1177/1533317513504614  0.68
2013 Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA. Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion. Oxidative Medicine and Cellular Longevity. 2013: 962984. PMID 23691268 DOI: 10.1155/2013/962984  0.68
2013 Aliev G. The role of oxidative stress, mitochondria failure, and cellular hypoperfusion in the context of alzheimer disease: Past, present and future The Role of Oxidative Stress, Mitochondria Failure, and Cellular Hypoperfusion in the Context of Alzheimer Disease: Past, Present and Future. 1-426.  0.68
2012 Kosenko EA, Aliev G, Tikhonova LA, Li Y, Poghosyan AC, Kaminsky YG. Antioxidant status and energy state of erythrocytes in Alzheimer dementia: probing for markers. Cns & Neurological Disorders Drug Targets. 11: 926-32. PMID 22998137 DOI: 10.2174/1871527311201070926  0.68
2012 Magalov SI, Hasanov NF, Azizova NX, Novruzov AN, Mustafayev ZB, Kazimov SA, Sultanov SSh, Hasanov EN, Aliev G. The prevalence of epilepsy in the Nakhichevan Autonomous Republic of Azerbaijan. Cns & Neurological Disorders Drug Targets. 11: 102-9. PMID 22229328  0.68
2012 Zhu X, Castellani RJ, Moreira PI, Aliev G, Shenk JC, Siedlak SL, Harris PL, Fujioka H, Sayre LM, Szweda PA, Szweda LI, Smith MA, Perry G. Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover. Free Radical Biology & Medicine. 52: 699-704. PMID 22137893 DOI: 10.1016/j.freeradbiomed.2011.11.004  1
2012 Aliev G, Li Y, Palacios HH, Obrenovich ME, Bragin V, Bragin I, Shevtsova E, Klochkov SG, Kosenko EA, Cacabelos R, Kaminsky YG, Bachurin SO, Benberin VV. Oxidative stress-induced mitochondrial damage as a hallmark for drug development in the context of the neurodegeneration, cardiovascular, and cerebrovascular diseases Systems Biology of Free Radicals and Antioxidants. 2083-2126. DOI: 10.1007/978-3-642-30018-9_208  1
2012 Aliev G, Kaminsky YG, Bragin V, Kosenko EA, Klochkov SG, Bachurin SO, Benberin VV. Flavones from the root of Scutellaria baicalensis georgi - Drugs of the future in neurodegeneration and neuroprotection? Systems Biology of Free Radicals and Antioxidants. 2305-2323. DOI: 10.1007/978-3-642-30018-9_207  1
2012 Aliev G, Burzynski G, Ashraf GM, Jabir NR, Cacabelos R, Benberin VV, Burzynski SR. Implication of oxidative stress-induced oncogenic signaling pathways as a treatment strategy for neurodegeneration and cancer Systems Biology of Free Radicals and Antioxidants. 2325-2347. DOI: 10.1007/978-3-642-30018-9_206  1
2012 Aliev G, Horecký J, Vančová O, Ashraf GM, Hassan I, Bragin V, Bragin I, Shevtsova E, Klochkov SG, Kosenko EA, Cacabelos R, Bachurin SO, Benberin VV, Kaminsky YG. The three-vessel occlusion as a model of vascular dementia - Oxidative stress and mitochondrial failure as an indicator of brain hypoperfusion Systems Biology of Free Radicals and Antioxidants. 2023-2032. DOI: 10.1007/978-3-642-30018-9_205  1
2012 Aliev G, Ashraf GM, Horecký J, Vančová O, Gvozdjáková A, Kucharská J, Palacios HH, Li Y, Perveen A, Khan TA, Bragin V, Bragin I, Shevtsova E, Klochkov SG, Kosenko EA, et al. Potential preventive effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion Systems Biology of Free Radicals and Antioxidants. 2033-2048. DOI: 10.1007/978-3-642-30018-9_204  1
2012 Aliev G, Li Y, Palacios HH, Obrenovich ME, Bragin V, Bragin I, Shevtsova E, Klochkov SG, Kosenko EA, Kaminsky YG, Bachurin SO, Cacabelos R. Atherosclerotic lesions and mitochondrial dna deletions as a primary hallmark of the brain microcirculation - Implication in the pathogenesis of Alzheimer's disease Systems Biology of Free Radicals and Antioxidants. 2127-2145. DOI: 10.1007/978-3-642-30018-9_203  1
2012 Kosenko EA, Tikhonova LA, Li Y, Poghosyan AC, Benberin VV, Kaminsky YG, Aliev G. Antioxidant status and energy state of erythrocytes in Alzheimer dementia - Potential probing for markers Systems Biology of Free Radicals and Antioxidants. 2289-2304. DOI: 10.1007/978-3-642-30018-9_202  1
2011 Aliev G, Li Y, Palacios HH, Obrenovich ME. Oxidative stress induced mitochondrial DNA deletion as a hallmark for the drug development in the context of the cerebrovascular diseases. Recent Patents On Cardiovascular Drug Discovery. 6: 222-41. PMID 21906026  0.68
2011 Horecký J, Gvozdjáková A, Kucharská J, Obrenovich ME, Palacios HH, Li Y, Vančová O, Aliev G. Effects of coenzyme Q and creatine supplementation on brain energy metabolism in rats exposed to chronic cerebral hypoperfusion. Current Alzheimer Research. 8: 868-75. PMID 21592049 DOI: 10.2174/156720511798192727  0.68
2011 Obrenovich ME, Li Y, Parvathaneni K, Yendluri BB, Palacios HH, Leszek J, Aliev G. Antioxidants in health, disease and aging. Cns & Neurological Disorders Drug Targets. 10: 192-207. PMID 21226664  1
2011 Sieradzki A, Yendluri BB, Palacios HH, Parvathaneni K, Reddy VP, Obrenovich ME, GÄ…siorowski K, Leszek J, Aliev G. Implication of oncogenic signaling pathways as a treatment strategy for neurodegenerative disorders - contemporary approaches. Cns & Neurological Disorders Drug Targets. 10: 175-83. PMID 21222633  0.68
2011 Gasiorowski K, Lamer-Zarawska E, Leszek J, Parvathaneni K, Yendluri BB, BÅ‚ach-Olszewska Z, Aliev G. Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration? Cns & Neurological Disorders Drug Targets. 10: 184-91. PMID 21222632  1
2011 Palacios HH, Yendluri BB, Parvathaneni K, Shadlinski VB, Obrenovich ME, Leszek J, Gokhman D, GÄ…siorowski K, Bragin V, Aliev G. Mitochondrion-specific antioxidants as drug treatments for Alzheimer disease. Cns & Neurological Disorders Drug Targets. 10: 149-62. PMID 21222631  1
2011 Aliev G. Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. Cns & Neurological Disorders Drug Targets. 10: 147-8. PMID 21222630  1
2011 Aliev G, Palacios HH, Betts B, Obrenovich ME, Gasiorowski K, Gokhman D, Leszek J, Bragin V, Herrera AS. Mitochondrion selective antioxidants as drug treatments for Alzheimer disease Vascular Dementia: Risk Factors, Diagnosis and Treatment. 105-128.  0.68
2011 Aliev G, Palacios HH, Herrera AS, Obrenovich ME. GRK2 Overexpression is a primary hallmark of vascular hypoperfusion and mitochondrial lesions during early Alzheimer disease: New target for drug treatment? Vascular Dementia: Risk Factors, Diagnosis and Treatment. 79-103.  0.68
2011 Aliev G, Palacios HH, Obrenovich ME, Gokhman D, Gasiorowski K, Bragin V, Herrera AS. Oxidative stress induced vascular hypoperfusion, mitochondrial failure are missing links for the development of Alzheimer disease Vascular Dementia: Risk Factors, Diagnosis and Treatment. 49-78.  0.68
2011 Obrenovich ME, Gasiorowski K, Palacios HH, Gokhman D, Shadlinski VB, Bragin V, Leszek J, Aliev G. Selective loss of GRK2 regulation and its consequences: Cerebrovascular complications and alzheimer disease | Wybiórczy ubytek w zakresie regulacji GRK2 i jego konsekwencje: Powikłania naczyniowo-mózgowe i choroba alzheimera Psychogeriatria Polska. 8: 81-98.  0.68
2011 Aliev G, Palacios HH, Bhushan BY, Gasiorowski K, Gokhman D, Shadlinski VB, Bragin V, Leszek J. Oxidative stress-induced mitochondrial DNA overproliferation and deletion, cellular hypoperfusion and brain hypometabolism in the context of cerebrovascular and Alzheimer disease: Offer new and successful targets for the drug delivering and treatment | Nadmierny rozrost i zanik mitochondrialnego DNA spowodowane stresem tlenowym,zmniejszeniem perfuzji i metabolizmu tkanki mózgowej w chorobie naczyniowej mózgu i alzheimera: Nowa oferta skutecznej terapii Psychogeriatria Polska. 8: 23-30.  0.68
2010 Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Solís Herrera A, Gokhman D. Oxidative Stress Induced Mitochondrial Failure and Vascular Hypoperfusion as a Key Initiator for the Development of Alzheimer Disease. Pharmaceuticals (Basel, Switzerland). 3: 158-187. PMID 27713247 DOI: 10.3390/ph3010158  1
2010 Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP. The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Research. 13: 631-43. PMID 20818981 DOI: 10.1089/rej.2010.1043  1
2010 Vančová O, Bačiak L, KaÅ¡parová S, Kucharská J, Palacios HH, Horecký J, Aliev G. In vivo and in vitro assessment of brain bioenergetics in aging rats. Journal of Cellular and Molecular Medicine. 14: 2667-74. PMID 19906014 DOI: 10.1111/j.1582-4934.2009.00879.x  1
2010 Aliev G, Palacios HH, Gasimov E, Obrenovich ME, Morales L, Leszek J, Bragin V, Herrera AS, Gokhman D. Oxidative stress induced mitochondrial failure and vascular hypoperfusion as a key initiator for the development of alzheimer disease Pharmaceuticals. 3: 158-187. DOI: 10.3390/ph3010158  1
2010 Horecký J, Aliev G, Gvozdjáková A, Kucharská J, Vančová O. Preventive and therapeutic coenzyme Q10 supplementation in rat subjected to cerebrovascular ischemia-reperfusion injury Current Neurobiology. 1: 30-36.  1
2009 Obrenovich ME, Palacios HH, Gasimov E, Leszek J, Aliev G. The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease. Cardiovascular Psychiatry and Neurology. 2009: 327360. PMID 20204079 DOI: 10.1155/2009/327360  1
2009 Aliev G, Palacios HH, Walrafen B, Lipsitt AE, Obrenovich ME, Morales L. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease. The International Journal of Biochemistry & Cell Biology. 41: 1989-2004. PMID 19703659 DOI: 10.1016/j.biocel.2009.03.015  1
2009 Aliev G, Palacios HH, Lipsitt AE, Fischbach K, Lamb BT, Obrenovich ME, Morales L, Gasimov E, Bragin V. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotoxicity Research. 16: 293-305. PMID 19526276 DOI: 10.1007/s12640-009-9066-5  1
2009 Shenk JC, Liu J, Fischbach K, Xu K, Puchowicz M, Obrenovich ME, Gasimov E, Alvarez LM, Ames BN, Lamanna JC, Aliev G. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. Journal of the Neurological Sciences. 283: 199-206. PMID 19342064 DOI: 10.1016/j.jns.2009.03.002  1
2009 Obrenovich ME, Morales LA, Cobb CJ, Shenk JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G, Aliev G. Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation. Journal of Cellular and Molecular Medicine. 13: 853-65. PMID 19292735 DOI: 10.1111/j.1582-4934.2008.00512.x  1
2009 Horecký J, Baciak L, Kasparová S, Pacheco G, Aliev G, Vancová O. Minimally invasive surgical approach for three-vessel occlusion as a model of vascular dementia in the rat-brain bioenergetics assay. Journal of the Neurological Sciences. 283: 178-81. PMID 19272617 DOI: 10.1016/j.jns.2009.02.348  1
2009 Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, Obrenovich ME, Ward WF, Richardson AG, Smith MA, Gasimov E, Perry G, Ames BN. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. Journal of Cellular and Molecular Medicine. 13: 320-33. PMID 18373733 DOI: 10.1111/j.1582-4934.2008.00324.x  1
2009 Aliev G, Palacios HH, Pacheco GJ, Gasimov E, Morales L, Gokhman D, Obrenovich ME, Bragin V, Soils A, Leszek J. Oxidative stress induced mitochondrial failure and cellular hypoperfusion: Implication in the pathogenesis of Alzheimer disease Psychogeriatria Polska. 6: 155-179.  1
2008 Aliev G, Obrenovich ME, Reddy VP, Shenk JC, Moreira PI, Nunomura A, Zhu X, Smith MA, Perry G. Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Reviews in Medicinal Chemistry. 8: 1395-406. PMID 18991755 DOI: 10.2174/138955708786369582  1
2008 Aliev G, Gasimov E, Obrenovich ME, Fischbach K, Shenk JC, Smith MA, Perry G. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vascular Health and Risk Management. 4: 721-30. PMID 18827923  1
2008 Aliev G, Shenk JC, Fischbach K, Perry G. Stem cell niches as clinical targets: the future of anti-ischemic therapy? Nature Clinical Practice. Cardiovascular Medicine. 5: 590-1. PMID 18628773 DOI: 10.1038/ncpcardio1295  1
2008 Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radical Biology & Medicine. 44: 1493-505. PMID 18258207 DOI: 10.1016/j.freeradbiomed.2008.01.002  1
2008 Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 4: 151-75. PMID 18188003  1
2007 Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Increased autophagic degradation of mitochondria in Alzheimer disease. Autophagy. 3: 614-5. PMID 17786024  1
2007 Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 66: 525-32. PMID 17549012 DOI: 10.1097/01.jnen.0000240476.73532.b0  1
2007 Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PL, Siedlak SL, Perry G. Vascular oxidative stress in Alzheimer disease. Journal of the Neurological Sciences. 257: 240-6. PMID 17337008 DOI: 10.1016/j.jns.2007.01.039  1
2007 Moreira PI, Nunomura A, Honda K, Aliev G, Casadesus G, Zhu X, Smith MA, Perry G. The key role of oxidative stress in alzheimer's disease Oxidative Stress and Neurodegenerative Disorders. 267-281. DOI: 10.1016/B978-044452809-4/50153-8  1
2006 Aliev G, Miller JP, Leifer DW, Obrenovich ME, Shenk JC, Smith MA, Lamanna JC, Perry G, Lust DW, Cohen AR. Ultrastructural analysis of a murine model of congenital hydrocephalus produced by overexpression of transforming growth factor-beta1 in the central nervous system. Journal of Submicroscopic Cytology and Pathology. 38: 85-91. PMID 17784635  1
2006 Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G, Aliev G. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotoxicity Research. 10: 43-56. PMID 17000469 DOI: 10.1007/BF03033333  1
2006 Zhu X, Perry G, Moreira PI, Aliev G, Cash AD, Hirai K, Smith MA. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. Journal of Alzheimer's Disease : Jad. 9: 147-53. PMID 16873962  1
2005 Moreira PI, Honda K, Liu Q, Santos MS, Oliveira CR, Aliev G, Nunomura A, Zhu X, Smith MA, Perry G. Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Current Alzheimer Research. 2: 403-8. PMID 16248845 DOI: 10.2174/156720505774330537  1
2005 Aliyev A, Chen SG, Seyidova D, Smith MA, Perry G, de la Torre J, Aliev G. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease. Journal of the Neurological Sciences. 229: 285-92. PMID 15760652 DOI: 10.1016/j.jns.2004.11.040  1
2005 Moreira PI, Smith MA, Zhu X, Honda K, Lee HG, Aliev G, Perry G. Oxidative damage and Alzheimer's disease: are antioxidant therapies useful? Drug News & Perspectives. 18: 13-9. PMID 15753972 DOI: 10.1358/dnp.2005.18.1.877164  1
2005 Bragin V, Chemodanova M, Dzhafarova N, Bragin I, Czerniawski JL, Aliev G. Integrated treatment approach improves cognitive function in demented and clinically depressed patients. American Journal of Alzheimer's Disease and Other Dementias. 20: 21-6. PMID 15751450  1
2005 Liu Q, Smith MA, Avilá J, DeBernardis J, Kansal M, Takeda A, Zhu X, Nunomura A, Honda K, Moreira PI, Oliveira CR, Santos MS, Shimohama S, Aliev G, de la Torre J, et al. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radical Biology & Medicine. 38: 746-54. PMID 15721985 DOI: 10.1016/j.freeradbiomed.2004.11.005  1
2005 de la Torre JC, Aliev G. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 663-72. PMID 15703700 DOI: 10.1038/sj.jcbfm.9600057  1
2005 Moreira PI, Siedlak SL, Aliev G, Zhu X, Cash AD, Smith MA, Perry G. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease. Journal of Neural Transmission (Vienna, Austria : 1996). 112: 921-32. PMID 15583960 DOI: 10.1007/s00702-004-0242-8  1
2005 Aliev G, Obrenovich ME, Seyidova D, de la Torre JC. Exploring ischemia-induced vascular lesions and potential pharmacological intervention strategies. Histology and Histopathology. 20: 261-73. PMID 15578444  1
2005 Moreira PI, Honda K, Liu Q, Aliev G, Oliveira CR, Santos MS, Zhu X, Smith MA, Perry G. Alzheimer's disease and oxidative stress: The old problem remains unsolved Current Medicinal Chemistry - Central Nervous System Agents. 5: 51-62.  1
2004 Aliev G, Smith MA, de la Torre JC, Perry G. Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion. 4: 649-63. PMID 16120422 DOI: 10.1016/j.mito.2004.07.018  1
2004 Aliev G, Castellani RJ, Petersen RB, Burnstock G, Perry G, Smith MA. Pathobiology of familial hypercholesterolemic atherosclerosis. Journal of Submicroscopic Cytology and Pathology. 36: 225-40. PMID 15906597  1
2004 Zhu X, Smith MA, Perry G, Aliev G. Mitochondrial failures in Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias. 19: 345-52. PMID 15633943  1
2004 de la Torre J, Aliev G, Perry G. Drug therapy in Alzheimer's disease. The New England Journal of Medicine. 351: 1911-3; author reply. PMID 15509830 DOI: 10.1056/NEJM200410283511822  1
2004 Seyidova D, Aliyev A, Rzayev N, Obrenovich M, Lamb BT, Smith MA, de la Torre JC, Perry G, Aliev G. The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease. In Vivo (Athens, Greece). 18: 325-33. PMID 15341188  1
2004 Aliyev A, Seyidova D, Rzayev N, Obrenovich ME, Lamb BT, Chen SG, Smith MA, Perry G, de la Torre JC, Aliev G. Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease? Neurological Research. 26: 547-53. PMID 15265272 DOI: 10.1179/01610425017613  1
2004 Casadesus G, Smith MA, Zhu X, Aliev G, Cash AD, Honda K, Petersen RB, Perry G. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. Journal of Alzheimer's Disease : Jad. 6: 165-9. PMID 15096700  1
2003 Aliev G, Smith MA, Obrenovich ME, de la Torre JC, Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotoxicity Research. 5: 491-504. PMID 14715433 DOI: 10.1007/BF03033159  1
2003 Aliev G, Obrenovich ME, Seyidova D, Rzayev NM, Aliyev AS, Raina AK, Lamanna JC, Smith MA, Perry G. X-ray contrast media induce aortic endothelial damage, which can be prevented with prior heparin treatment. Journal of Submicroscopic Cytology and Pathology. 35: 253-66. PMID 14690173  1
2003 Lee HG, Petersen RB, Zhu X, Honda K, Aliev G, Smith MA, Perry G. Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? Brain Pathology (Zurich, Switzerland). 13: 630-8. PMID 14655766  1
2003 Perry G, Nunomura A, Raina AK, Aliev G, Siedlak SL, Harris PL, Casadesus G, Petersen RB, Bligh-Glover W, Balraj E, Petot GJ, Smith MA. A metabolic basis for Alzheimer disease. Neurochemical Research. 28: 1549-52. PMID 14570400 DOI: 10.1023/A:1025678510480  1
2003 Aliev G, Seyidova D, Lamb BT, Obrenovich ME, Siedlak SL, Vinters HV, Friedland RP, LaManna JC, Smith MA, Perry G. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurological Research. 25: 665-74. PMID 14503022 DOI: 10.1179/016164103101201977  1
2003 Aliev G, Obrenovich ME, Smith MA, Perry G. Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease. Journal of Biomedicine & Biotechnology. 2003: 162-163. PMID 12975531 DOI: 10.1155/S1110724303305029  1
2003 Cash AD, Aliev G, Siedlak SL, Nunomura A, Fujioka H, Zhu X, Raina AK, Vinters HV, Tabaton M, Johnson AB, Paula-Barbosa M, Avíla J, Jones PK, Castellani RJ, Smith MA, et al. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. The American Journal of Pathology. 162: 1623-7. PMID 12707046  1
2003 Perry G, Ávila J, Casadesus G, Nunomura A, Tabaton M, Cash A, Aliev G, Wataya T, Shimohama S, Drew K, Atwood C, Smith M. The role of oxidative stress in the pathogenesis of Alzheimer's disease | La función del estrés oxidativo en la patogénesis de la enfermedad de Alzheimer Revista Chilena De Neuro-Psiquiatria. 41: 47-52.  1
2002 Aliev G. Is non-genetic Alzheimer's disease a vascular disorder with neurodegenerative consequences? Journal of Alzheimer's Disease : Jad. 4: 513-6. PMID 12515902  1
2002 Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Annals of the New York Academy of Sciences. 977: 45-64. PMID 12480733  1
2002 Perry G, Nunomura A, Cash AD, Taddeo MA, Hirai K, Aliev G, Avila J, Wataya T, Shimohama S, Atwood CS, Smith MA. Reactive oxygen: its sources and significance in Alzheimer disease. Journal of Neural Transmission. Supplementum. 69-75. PMID 12456052  1
2002 Perry G, Nunomura A, Hirai K, Zhu X, Pérez M, Avila J, Castellani RJ, Atwood CS, Aliev G, Sayre LM, Takeda A, Smith MA. Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radical Biology & Medicine. 33: 1475-9. PMID 12446204 DOI: 10.1016/S0891-5849(02)01113-9  1
2002 Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA. Role of mitochondrial dysfunction in Alzheimer's disease. Journal of Neuroscience Research. 70: 357-60. PMID 12391597 DOI: 10.1002/jnr.10389  1
2002 Shi J, Perry G, Berridge MS, Aliev G, Siedlak SL, Smith MA, LaManna JC, Friedland RP. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 1044-51. PMID 12163630  1
2002 Aliev G, Smith MA, Seyidova D, Neal ML, Shi J, Loizidou M, Turmaine M, Friedland RP, Taylor I, Burnstock G, Perry G, Lamanna JC. Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumours is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium. Journal of Submicroscopic Cytology and Pathology. 34: 37-50. PMID 11989855  1
2002 Aliev G, Smith MA, Seyidov D, Neal ML, Lamb BT, Nunomura A, Gasimov EK, Vinters HV, Perry G, LaManna JC, Friedland RP. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 12: 21-35. PMID 11770899  1
2001 Aliev G, Seyidov D, Neal ML, Shi J, Vigan T, Hernandez A, Folco G, Soas AH, Zimina TV, Smith MA, Perry G, Lamanna JC, Friedland RP. The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro. Journal of Submicroscopic Cytology and Pathology. 33: 141-9. PMID 11686395  1
2001 Aliev G, Smith MA, Turmaine M, Neal ML, Zimina TV, Friedland RP, Perry G, LaManna JC, Burnstock G. Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin-1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. Experimental and Molecular Pathology. 71: 40-54. PMID 11502096 DOI: 10.1006/exmp.2001.2380  1
2001 Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA. Oxidative damage is the earliest event in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 60: 759-67. PMID 11487050  1
2001 Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, et al. Mitochondrial abnormalities in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 3017-23. PMID 11312286  1
2001 Zhu X, Raina AK, Rottkamp CA, Aliev G, Perry G, Boux H, Smith MA. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. Journal of Neurochemistry. 76: 435-41. PMID 11208906 DOI: 10.1046/j.1471-4159.2001.00046.x  1
2000 Aliev G, Shi J, Perry G, Friedland RP, Lamanna JC. Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet. The Anatomical Record. 260: 16-25. PMID 10967532 DOI: 10.1002/1097-0185(20000901)260:1<16::AID-AR20>3.0.CO;2-2  1
2000 Perry G, Nunomura A, Hirai K, Takeda A, Aliev G, Smith MA. Oxidative damage in Alzheimer's disease: the metabolic dimension. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 18: 417-21. PMID 10817925 DOI: 10.1016/S0736-5748(00)00006-X  1
1999 Aliev G, Ragazzi E, Smith MA, Mironov A, Perry G. Morphological features of regeneration of rabbit aortic endothelium after cryoinduced vascular damage. Journal of Submicroscopic Cytology and Pathology. 31: 495-502. PMID 10685390  1
1999 Nunomura A, Perry G, Hirai K, Aliev G, Takeda A, Chiba S, Smith MA. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Annals of the New York Academy of Sciences. 893: 362-4. PMID 10672267  1
1999 Shi J, Perry G, Aliev G, Smith MA, Ashe KH, Friedland RP. Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model. Neuroreport. 10: 3229-32. PMID 10574565  1
1998 Aliev G, Ragazzi E, Cirillo R, Bevilacqua C, Mironov A, Prosdocimi M, Paro M. Cryodamage of the vessel wall accelerates the development of atherosclerotic lesions in arterial vessels of Watanabe hyperlipidemic rabbits. Journal of Submicroscopic Cytology and Pathology. 30: 417-23. PMID 9723203  0.52
1998 Aliev G, Burnstock G. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Histology and Histopathology. 13: 797-817. PMID 9690137  1
1998 Aliev G, Bodin P, Burnstock G. Free radical generators cause changes in endothelial and inducible nitric oxide synthases and endothelin-1 immunoreactivity in endothelial cells from hyperlipidemic rabbits. Molecular Genetics and Metabolism. 63: 191-7. PMID 9608541 DOI: 10.1006/mgme.1997.2664  1
1998 Shankar A, Loizidou M, Aliev G, Fredericks S, Holt D, Boulos PB, Burnstock G, Taylor I. Raised endothelin 1 levels in patients with colorectal liver metastases. The British Journal of Surgery. 85: 502-6. PMID 9607532 DOI: 10.1046/j.1365-2168.1998.00660.x  1
1996 Ralevic V, Aliev G, Burnstock G. Mesenteric and hepatic vascular reactivity in Donryu rats with and without a cholesterol-supplemented diet. European Journal of Pharmacology. 313: 221-7. PMID 8911918  1
1996 Aliev G, Ralevic V, Burnstock G. Depression of endothelial nitric oxide synthase but increased expression of endothelin-1 immunoreactivity in rat thoracic aortic endothelium associated with long-term, but not short-term, sympathectomy. Circulation Research. 79: 317-23. PMID 8756010  1
1996 Sala A, Aliev GM, Rossoni G, Berti F, Buccellati C, Burnstock G, Folco G, Maclouf J. Morphological and functional changes of coronary vasculature caused by transcellular biosynthesis of sulfidopeptide leukotrienes in isolated heart of rabbit. Blood. 87: 1824-32. PMID 8634429  1
1995 Aliev G, Miah S, Turmaine M, Burnstock G. An ultrastructural and immunocytochemical study of thoracic aortic endothelium in aged Sprague-Dawley rats. Journal of Submicroscopic Cytology and Pathology. 27: 477-90. PMID 7585446  1
1995 Ragazzi E, Chinellato A, Pandolfo L, Froldi G, Caparrotta L, Aliev G, Prosdocimi M, Fassina G. Endothelial nucleotide-mediated aorta relaxation in aged Watanabe heritable hyperlipidemic rabbits. Journal of Cardiovascular Pharmacology. 26: 119-26. PMID 7564351  1
1994 Chinellato A, Ragazzi E, Petrelli L, Paro M, Mironov A, Aliev G. Effect of cholesterol-supplemented diet in heritable hyperlipidemic Yoshida rats: functional and morphological characterization of thoracic aorta. Atherosclerosis. 106: 51-63. PMID 8018107 DOI: 10.1016/0021-9150(94)90082-5  1
1994 Chinellato A, Ragazzi E, Pandolfo L, Alvano AP, Froldi G, De Biasi M, Caparrotta L, Aliev G, Fassina G. Functional and morphologic characterization of thoracic aorta in heritable hyperlipidemic Yoshida rats of different ages. Journal of Cardiovascular Pharmacology. 24: 216-28. PMID 7526053  1
1993 Caparrotta L, Pandolfo L, Chinellato A, Ragazzi E, Froldi G, Aliev G, Fassina G. L-Arginine does not improve endothelium-dependent relaxation inin vitro Watanabe rabbit thoracic aorta. Amino Acids. 5: 403-11. PMID 24190711 DOI: 10.1007/BF00806958  1
1993 Ragazzi E, Chinellato A, Pandolfo L, Froldi G, Caparrotta L, Prosdocimi M, Aliev G, Fassina G. Atherosclerosis-related remodeling of aortic relaxation to purines in the Watanabe heritable hyperlipidemic rabbit. The Journal of Pharmacology and Experimental Therapeutics. 266: 1091-6. PMID 8355183  1
1993 Aliev G, Mironov A, Cirillo R, Mironov A, Gorelova E, Prosdocimi M. Evidence for the presence of early vascular lesions in newborn Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis. 101: 17-24. PMID 8216499  0.52
Show low-probability matches.